Crescent Capital BDC (CCAP) EBITDA (2021 - 2026)

Crescent Capital BDC has reported EBITDA for 6 years, with the latest figure at -$21.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 12.55% year-over-year to -$21.9 million; the trailing twelve-month figure through Mar 2026 stood at $111.1 million (up 305.31% YoY), and the FY2025 full-year result was $66.9 million, up 162.67% from the prior year.
• EBITDA for Q1 2026 stood at -$21.9 million, down from $141.8 million in the prior quarter.
• The five-year high for EBITDA was $141.8 million in Q4 2025, with the low at -$160.1 million in Q4 2023.
• Historically, EBITDA has averaged -$1.6 million across 5 years, with a median of -$14.1 million in 2022.
• Annual changes were most pronounced in 2022 — EBITDA jumped 1008.51% — and 2023, when it sank 266.28%.
• Crescent Capital BDC's EBITDA stood at $98.2 million in 2022, then tumbled by 263.04% to -$160.1 million in 2023, then surged by 83.85% to -$25.8 million in 2024, then soared by 648.54% to $141.8 million in 2025, then plunged by 115.42% to -$21.9 million in 2026.
• The last three EBITDA figures came in at -$21.9 million (Q1 2026), $141.8 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.